A Phase II Study of Erlotinib as First-Line Treatment in Japanese Advanced NSCLC Patients Harboring EGFR Mutations
Year: 2012
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Authors: A. Horiike, M. Nishio, K. Goto, N. Yamamoto, K. Chikamori, M. Maemondo, T. Hida, N. Katakami, T. Tamura
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3000286752
